Literature DB >> 32859711

First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer.

Mika Naganawa1, Nabeel Nabulsi2, Shannan Henry2, David Matuskey2, Shu-Fei Lin2, Lawrence Slieker3, Adam J Schwarz3, Nancy Kant3, Cynthia Jesudason3, Kevin Ruley3, Antonio Navarro3, Hong Gao2, Jim Ropchan2, David Labaree2, Richard E Carson2, Yiyun Huang2.   

Abstract

This was a first-in-human study of the PET radiotracer 11C-LSN3172176 for the muscarinic acetylcholine receptor subtype M1. The objectives of the study were to determine the appropriate kinetic model to quantify binding of the tracer to M1 receptors, and the reliability of the chosen quantification method.
Methods: Six healthy subjects completed the test-retest protocol, and 5 healthy subjects completed the baseline-scopolamine blocking protocol. Multiple modeling methods were applied to calculate total distribution volume (V T) and nondisplaceable binding potential (BP ND) in various brain regions. The reference region was selected from the blocking study. The occupancy plot was applied to compute receptor occupancy by scopolamine and nondisplaceable distribution volume.
Results: Tracer uptake was highest in the striatum, followed by neocortical regions and white matter, and lowest in the cerebellum. Regional time-activity curves were fitted well by all models. The 2-tissue-compartment (2TC) model fits were good, but the 2TC parameters often could not be reliably estimated. Because V T correlated well between the 2TC and 1-tissue-compartment (1TC) models after exclusion of unreliable estimates, the 1TC model was chosen as the most appropriate. The cerebellum showed the lowest V T, consistent with preclinical studies showing little to no specific binding in the region. Further, cerebellar V T did not change between baseline and blocking scans, indicating that the cerebellum is a suitable reference region. The simplified reference tissue model (SRTM) slightly underestimated 1TC BP ND, and the simplified reference tissue model 2 (SRTM2) improved BP ND estimation. An 80-min scan was sufficient to quantify V T and BP ND The test-retest study showed excellent absolute test-retest variability for 1TC V T (≤5%) and BP ND (≤10%). In the baseline and blocking studies, occupancy values were lower in the striatum than in nonstriatal regions, as may be attributed to differences in regional acetylcholine concentrations.
Conclusion: The 1TC and SRTM2 models are appropriate for quantitative analysis of 11C-LSN3172176 imaging data. 11C-LSN3172176 displayed excellent test-retest reproducibility and is a highly promising ligand to quantify M1 receptors in the human brain.
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  PET; brain imaging; muscarinic acetylcholine receptor 1; scopolamine; test–retest reproducibility

Year:  2020        PMID: 32859711      PMCID: PMC8049371          DOI: 10.2967/jnumed.120.246967

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  34 in total

1.  Evaluation of motion correction methods in human brain PET imaging--a simulation study based on human motion data.

Authors:  Xiao Jin; Tim Mulnix; Jean-Dominique Gallezot; Richard E Carson
Journal:  Med Phys       Date:  2013-10       Impact factor: 4.071

2.  Enhancement of MR images using registration for signal averaging.

Authors:  C J Holmes; R Hoge; L Collins; R Woods; A W Toga; A C Evans
Journal:  J Comput Assist Tomogr       Date:  1998 Mar-Apr       Impact factor: 1.826

3.  Direct targeted quantitative molecular imaging of neurotransmitters in brain tissue sections.

Authors:  Mohammadreza Shariatgorji; Anna Nilsson; Richard J A Goodwin; Patrik Källback; Nicoletta Schintu; Xiaoqun Zhang; Alan R Crossman; Erwan Bezard; Per Svenningsson; Per E Andren
Journal:  Neuron       Date:  2014-11-06       Impact factor: 17.173

4.  Quantitative PET Imaging in Drug Development: Estimation of Target Occupancy.

Authors:  Mika Naganawa; Jean-Dominique Gallezot; Samantha Rossano; Richard E Carson
Journal:  Bull Math Biol       Date:  2017-12-11       Impact factor: 1.758

5.  Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.

Authors:  Mika Naganawa; Ming-Qiang Zheng; Shannan Henry; Nabeel Nabulsi; Shu-Fei Lin; Jim Ropchan; David Labaree; Soheila Najafzadeh; Michael Kapinos; Johannes Tauscher; Alexander Neumeister; Richard E Carson; Yiyun Huang
Journal:  J Nucl Med       Date:  2015-01-15       Impact factor: 10.057

6.  Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans.

Authors:  W Gordon Frankle; Yiyun Huang; Dah-Ren Hwang; Peter S Talbot; Mark Slifstein; Ronald Van Heertum; Anissa Abi-Dargham; Marc Laruelle
Journal:  J Nucl Med       Date:  2004-04       Impact factor: 10.057

7.  Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: an in vivo microdialysis study.

Authors:  J Day; G Damsma; H C Fibiger
Journal:  Pharmacol Biochem Behav       Date:  1991-04       Impact factor: 3.533

8.  Effects of cholinergic drugs on extracellular levels of acetylcholine and choline in rat cortex, hippocampus and striatum studied by brain dialysis.

Authors:  K Toide; T Arima
Journal:  Eur J Pharmacol       Date:  1989-12-07       Impact factor: 4.432

9.  Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain.

Authors:  D C Mash; L T Potter
Journal:  Neuroscience       Date:  1986-10       Impact factor: 3.590

Review 10.  Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging.

Authors:  Vladimir Shalgunov; Aren van Waarde; Jan Booij; Martin C Michel; Rudi A J O Dierckx; Philip H Elsinga
Journal:  Med Res Rev       Date:  2018-11-18       Impact factor: 12.944

View more
  7 in total

1.  neuromaps: structural and functional interpretation of brain maps.

Authors:  Ross D Markello; Justine Y Hansen; Zhen-Qi Liu; Vincent Bazinet; Golia Shafiei; Laura E Suárez; Nadia Blostein; Jakob Seidlitz; Sylvain Baillet; Theodore D Satterthwaite; M Mallar Chakravarty; Armin Raznahan; Bratislav Misic
Journal:  Nat Methods       Date:  2022-10-06       Impact factor: 47.990

Review 2.  A review on pathology, mechanism, and therapy for cerebellum and tremor in Parkinson's disease.

Authors:  Yuke Zhong; Hang Liu; Guohui Liu; Lili Zhao; Chengcheng Dai; Yi Liang; Juncong Du; Xuan Zhou; Lijuan Mo; Changhong Tan; Xinjie Tan; Fen Deng; Xi Liu; Lifen Chen
Journal:  NPJ Parkinsons Dis       Date:  2022-06-24

3.  PET Imaging Estimates of Regional Acetylcholine Concentration Variation in Living Human Brain.

Authors:  Kelly Smart; Mika Naganawa; Stephen R Baldassarri; Nabeel Nabulsi; Jim Ropchan; Soheila Najafzadeh; Hong Gao; Antonio Navarro; Vanessa Barth; Irina Esterlis; Kelly P Cosgrove; Yiyun Huang; Richard E Carson; Ansel T Hillmer
Journal:  Cereb Cortex       Date:  2021-05-10       Impact factor: 5.357

Review 4.  Update on PET Tracer Development for Muscarinic Acetylcholine Receptors.

Authors:  Marius Ozenil; Jonas Aronow; Marlon Millard; Thierry Langer; Wolfgang Wadsak; Marcus Hacker; Verena Pichler
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-02

5.  A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [18F]SDM-16.

Authors:  Chao Zheng; Daniel Holden; Ming-Qiang Zheng; Richard Pracitto; Kyle C Wilcox; Marcel Lindemann; Zachary Felchner; Li Zhang; Jie Tong; Krista Fowles; Sjoerd J Finnema; Nabeel Nabulsi; Richard E Carson; Yiyun Huang; Zhengxin Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-11-11       Impact factor: 10.057

6.  Local molecular and global connectomic contributions to cross-disorder cortical abnormalities.

Authors:  Justine Y Hansen; Golia Shafiei; Jacob W Vogel; Kelly Smart; Carrie E Bearden; Martine Hoogman; Barbara Franke; Daan van Rooij; Jan Buitelaar; Carrie R McDonald; Sanjay M Sisodiya; Lianne Schmaal; Dick J Veltman; Odile A van den Heuvel; Dan J Stein; Theo G M van Erp; Christopher R K Ching; Ole A Andreassen; Tomas Hajek; Nils Opel; Gemma Modinos; André Aleman; Ysbrand van der Werf; Neda Jahanshad; Sophia I Thomopoulos; Paul M Thompson; Richard E Carson; Alain Dagher; Bratislav Misic
Journal:  Nat Commun       Date:  2022-08-10       Impact factor: 17.694

Review 7.  Looking Back at the Next 40 Years of ASD Neuroscience Research.

Authors:  James C McPartland; Matthew D Lerner; Anjana Bhat; Tessa Clarkson; Allison Jack; Sheida Koohsari; David Matuskey; Goldie A McQuaid; Wan-Chun Su; Dominic A Trevisan
Journal:  J Autism Dev Disord       Date:  2021-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.